drugset / Trial / NCT06756178
Effect of Remimazolam Versus Dexmedetomidine on the Incidence of Delirium After Elective Cardiac Surgery with Cardiopulmonary Bypass: a Prospective Randomized Controlled Trial
RandomizedParallel-groupDouble-blindPrevention
Summary
The study aims to improve the post-open heart surgery lifestyle and overall experience, as well as assess the incidence of delirium using Remimazolam and Dexmedetomidine.
Timeline
- Start
- 2025-01-10
- Primary completion
- 2026-11-01
- Completion
- 2027-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 0.2 ug/kg | — |
| Subject | Dexmedetomidine | Other / unclassified | 0.7 ug/kg | — |
| Comparator | Propofol | Small molecule | 0.3 mg/kg | Intravenous |
| Comparator | Propofol | Small molecule | 0.5 mg/kg | Intravenous |
| Subject | Remimazolam | Small molecule | 0.2 mg/kg | Intravenous |
| Subject | Remimazolam | Small molecule | 0.3 mg/kg | Intravenous |